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Background
The clinical management of bacterial infection computes
factors related to bacteria (e.g., resistance profile [1]),
antibiotics (e.g., activity spectrum, distribution volume,
etc.), host characteristics (e.g., vascularization of the
infected tissue, effectiveness of host defenses, etc.), as
well as pharmacokinetic (PK) parameters [2]. The serum
inhibitory (SIT) and bactericidal titers (SBT) are labora-
tory tests that simulate the interactions between antibio-
tics and bacteria in the human body milieu.
Methods
In the Emergency Laboratory of the Adults 2 Clinical
Ward of the National Institute for Infectious Diseases
“Prof. Dr. Matei Balş”, we consistently perform SIT and
SBT in complicated cases of bacterial infections. We
have retrospectively collected and analyzed data from
such tests performed between 2012 and 2014 and corre-
lated the results with the patient’s overall clinical evolu-
tion. We present the descriptive results.
Results
We have analyzed 89 cases. The serum antibiotics tested
were: linezolid (15 cases, 16.9%), carbapenems (12 cases,
13.5%) with (5 cases) and without (7 cases) colistin, amino-
penicillins (10 cases, 11.2%), and in smaller percentages:
oxacillin, tigecycline, fluoroquinolones, trimethoprim/sul-
famethoxazole, glycopeptides, aminoglycosides, ceftaroline
and other cephalosporins.
In most cases serum samples were collected at the
time of peak PK, with the exception of three cases
where the trough concentration was examined instead.
The tested germs were mostly Staphylococcus spp.
(51.7%), followed by Enterococcus spp. (14.6%), Strepto-
coccus spp. (9%) and Gram-negative bacilli (24.7%) such
as: E. coli, Klebsiella spp. and Pseudomonas spp. The
strains had been isolated from blood cultures (49.4%),
cutaneous wounds (23.6%), tracheal aspirate (13.5%) and
urine samples (7.9%).
SIT ranged from 1/2 (12.4%) to 1/512 (5.6%), but only in
20 cases (22.4%) the titers were in the therapeutic comfort
range of 1/64 to 1/512. SBT ranged from 0 (11.2%) to
1/256 (6.7%). SIT and SBT were equal and in the comfort
range for 2 strains of wound Staphylococcus, 4 strains of
blood culture Staphylococcus, and 3 strains of tracheal
aspirate E. coli.
Conclusion
Interdisciplinary patient management and good colla-
boration with the bacteriology laboratory all contribute
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